Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Belotero Revive
- Development stage
- Phase 4
- Lead developer
- Merz Aesthetics
- Administration
- Intradermal
01
Overview
Belotero Revive is an injectable dermal filler and skin booster developed by Merz Aesthetics. It is a sterile, transparent, cross-linked hyaluronic acid (20 mg/mL) hydrogel combined with glycerol (17.5 mg/mL). Utilizing Merz's proprietary Cohesive Polydensified Matrix (CPM) technology, the product is designed for smooth integration into the superficial to mid-dermal layers of the skin. Unlike traditional fillers that focus on volume restoration, Belotero Revive is indicated for skin revitalization, improving hydration, elasticity, and firmness, and reducing fine lines in early-onset photo-damaged skin. It acts as a humectant and structural support agent within the extracellular matrix.
- Brand names
- Belotero Revive
02
Targets
COL (Collagen type XXI alpha 1 chain)
Beyond the preview
Go deeper on Belotero Revive.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Belotero Revive.